0001384101-23-000134.txt : 20230724
0001384101-23-000134.hdr.sgml : 20230724
20230724170652
ACCESSION NUMBER: 0001384101-23-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230719
FILED AS OF DATE: 20230724
DATE AS OF CHANGE: 20230724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JONES EVAN/ FA
CENTRAL INDEX KEY: 0001020741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 231105759
BUSINESS ADDRESS:
STREET 1: 9000 VIRGINIA MANOR ROAD
STREET 2: SUITE 206
CITY: BELTSVILLE
STATE: MD
ZIP: 20705
BUSINESS PHONE: 240-813-1260
MAIL ADDRESS:
STREET 1: C/O OPGEN, INC.
STREET 2: 708 QUINCE ORCHARD ROAD, SUITE 205
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
wk-form4_1690232803.xml
FORM 4
X0508
4
2023-07-19
0
0001384101
VERACYTE, INC.
VCYT
0001020741
JONES EVAN/ FA
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
0
Common Stock
2023-07-19
4
S
0
838
30.1398
D
37601
D
Common Stock
2023-07-19
4
S
0
3090
30.1723
D
35173
I
by jVen Capital, LLC
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2022.
Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 12, 2022.
Represents weighted average sales price. Sale prices for the transactions range from $30.01 to $30.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
The Reporting Person is the sole managing member of jVen Capital, LLC.
/s/ Jonathan Wygant, as attorney-in-fact
2023-07-24